Marshall KM - Search Results

1

Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges.

Antunes EM, Beukes DR, Kelly M, Samaai T, Barrows LR, Marshall KM, Sincich C, Davies-Coleman MT. Antunes EM, et al. Among authors: marshall km. J Nat Prod. 2004 Aug;67(8):1268-76. doi: 10.1021/np034084b. J Nat Prod. 2004. PMID: 15332840

2

Biological activities of pyridoacridines.

Marshall KM, Barrows LR. Marshall KM, et al. Nat Prod Rep. 2004 Dec;21(6):731-51. doi: 10.1039/b401662a. Epub 2004 Oct 29. Nat Prod Rep. 2004. PMID: 15565252 Review.

3

Identification of a small topoisomerase I-binding peptide that has synergistic antitumor activity with 9-aminocamptothecin.

Pond CD, Marshall KM, Barrows LR. Pond CD, et al. Among authors: marshall km. Mol Cancer Ther. 2006 Mar;5(3):739-45. doi: 10.1158/1535-7163.MCT-05-0377. Mol Cancer Ther. 2006. PMID: 16546989

4

AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex.

Marshall KM, Holden JA, Koller A, Kashman Y, Copp BR, Barrows LR. Marshall KM, et al. Anticancer Drugs. 2004 Oct;15(9):907-13. doi: 10.1097/00001813-200410000-00012. Anticancer Drugs. 2004. PMID: 15457132

5

Deoxyamphimedine, a pyridoacridine alkaloid, damages DNA via the production of reactive oxygen species.

Marshall KM, Andjelic CD, Tasdemir D, Concepción GP, Ireland CM, Barrows LR. Marshall KM, et al. Mar Drugs. 2009 May 25;7(2):196-209. doi: 10.3390/md7020196. Mar Drugs. 2009. PMID: 19597581 Free PMC article.

6

Deoxyamphimedine, a new pyridoacridine alkaloid from two tropical Xestospongia sponges.

Tasdemir D, Marshall KM, Mangalindan GC, Concepción GP, Barrows LR, Harper MK, Ireland CM. Tasdemir D, et al. Among authors: marshall km. J Org Chem. 2001 May 4;66(9):3246-8. doi: 10.1021/jo010153k. J Org Chem. 2001. PMID: 11325300 No abstract available.

7

The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine.

Marshall KM, Matsumoto SS, Holden JA, Concepción GP, Tasdemir D, Ireland CM, Barrows LR. Marshall KM, et al. Biochem Pharmacol. 2003 Aug 1;66(3):447-58. doi: 10.1016/s0006-2952(03)00209-0. Biochem Pharmacol. 2003. PMID: 12907244

8

Considerations of growth factor and material use in bone tissue engineering using biodegradable scaffolds in vitro and in vivo.

Marshall KM, Wojciechowski JP, Jayawarna V, Hasan A, Echalier C, Øvrebø Ø, Yang T, Zhou K, Kanczler JM, Mata A, Salmeron-Sanchez M, Stevens MM, Oreffo ROC. Marshall KM, et al. Sci Rep. 2024 Oct 28;14(1):25832. doi: 10.1038/s41598-024-75198-3. Sci Rep. 2024. PMID: 39468149 Free PMC article.

9

Bioactive coatings on 3D printed scaffolds for bone regeneration: Use of Laponite® to deliver BMP-2 in an ovine femoral condyle defect model.

Marshall KM, McLaren JS, Wojciechowski JP, Callens SJP, Echalier C, Kanczler JM, Rose FRAJ, Stevens MM, Dawson JI, Oreffo ROC. Marshall KM, et al. Biomater Adv. 2024 Nov;164:213959. doi: 10.1016/j.bioadv.2024.213959. Epub 2024 Jul 18. Biomater Adv. 2024. PMID: 39083876 Free article.

10

Effects of Low-Level Persistent Infection on Maintenance of Immunity by CD4 T Cell Subsets and Th1 Cytokines.

Ibitokou SA, Gbedande K, Opata MM, Carpio VH, Marshall KM, Stephens R. Ibitokou SA, et al. Among authors: marshall km. Infect Immun. 2023 Mar 15;91(3):e0053122. doi: 10.1128/iai.00531-22. Epub 2023 Feb 28. Infect Immun. 2023. PMID: 36920200 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters